Self-Limited & Absence Epilepsies
Self-Limited & Absence Epilepsies of Childhood
What You'll Learn
- Febrile seizures: Most common childhood seizure type (2–5%); simple FS carry epilepsy risk of 1–2% (same as general population); no routine EEG/imaging per AAP; FEBSTAT links prolonged febrile SE → MTS → TLE
- SeLECTS: Most common childhood focal epilepsy (15–25%); centrotemporal spikes with horizontal dipole; hemifacial sensorimotor seizures from sleep; remission by age 16 in virtually all
- CAE vs JAE: CAE = dozens of absences/day, 3 Hz spike-wave, HV provokes >90%, 60–70% remit; JAE = less frequent absences, 80% GTC, typically lifelong treatment
- CSWS/ESES: EEG pattern (SWI ≥50%) drives encephalopathy, NOT seizure frequency; overnight EEG is mandatory; treat with high-dose benzodiazepine pulse → corticosteroids
- Drugs to AVOID in absence: CBZ, OXC, PHT, VGB — worsen absence seizures and may precipitate absence status
- GRIN2A: Genetic link across the SeLECTS → LKS → CSWS spectrum (10–20% of CSWS/LKS)
HighYield Pearls
- SeLECTS / BECTS: hemifacial twitching + drooling + speech arrest with preserved awareness, mostly nocturnal/on awakening → centrotemporal spikes; remits by 16; treat only if frequent (LEV, OXC, VPA); AVOID polytherapy
- Panayiotopoulos (early-onset benign occipital, 3–6 yr): ictal autonomic features — vomiting, pallor, syncope — from sleep; seizures often >30 min (autonomic status); EEG multifocal shifting spikes; benign, AED often not needed
- Gastaut (late-onset childhood occipital, 6–14 yr): elementary visual hallucinations + ictal blindness + postictal migraine-like headache; daytime; occipital spikes block on eye opening; only ~1/3 remit; treat if frequent
- CAE: 4–10 yr, multiple brief absences with 3-Hz generalized spike-wave activated by hyperventilation; ethosuximide first-line (CAE trial: ETX > VPA > LTG for absence remission, ETX best attention profile)
- Jeavons (eyelid myoclonia with absences): eye-closure–induced eyelid myoclonia + photoparoxysmal response + absences; LIFELONG — AVOID lamotrigine (may worsen); VPA/LEV/clonazepam preferred
- AVOID Na-channel blockers (CBZ, OXC, PHT, GBP, PGB, TGB, VGB) in absence/myoclonic seizures — they worsen seizures and may precipitate absence/myoclonic status
- Ethosuximide = absence only (no GTC coverage); switch to VPA/LTG if GTC develops
- CSWS / ESES: continuous spike-wave in slow-wave sleep (≥85% NREM) + cognitive/language regression → high-dose benzodiazepine pulse, steroids/IVIG, clobazam; EEG burden drives the encephalopathy, not seizure count
- Genetics to know: GRIN2A (atypical SeLECTS / LKS / CSWS spectrum), CHD2 & GABRA1 (CAE/JME spectrum), SLC2A1 / GLUT1 deficiency (early-onset absence + myoclonic-atonic phenotype — ketogenic diet)
🔍 Quick ReferenceEEG · Clinical · Treatment / prognosis
EEG signs
- Centrotemporal spikes with horizontal dipole, activated by sleep → SeLECTS / BECTS
- 3-Hz generalized spike-and-wave activated by hyperventilation → Childhood absence epilepsy (CAE)
- Multifocal high-amplitude spikes, shifting localization, occipital predominance → Panayiotopoulos syndrome
- Occipital spikes that attenuate / block on eye opening (fixation-off sensitivity) → Gastaut late-onset occipital epilepsy
- Photoparoxysmal response with eye-closure–induced generalized polyspike-wave → Jeavons (eyelid myoclonia with absences)
- Continuous spike-wave ≥85% of NREM sleep (SWI) → CSWS / ESES
Clinical phenotype
- Nocturnal hemifacial twitching + drooling + speech arrest, awareness preserved, school-age child → SeLECTS / BECTS
- Ictal vomiting, pallor, syncope, prolonged seizure >30 min from sleep in a preschooler → Panayiotopoulos syndrome
- Elementary visual hallucinations (colored circles) + ictal blindness + postictal migraine → Gastaut occipital epilepsy
- Dozens of brief blank stares per day, provoked by hyperventilation in a 6–8 yr old → CAE
- Rhythmic eyelid fluttering + upward eye deviation triggered by eye closure / bright light → Jeavons syndrome
- Cognitive / language regression with nocturnal seizures and abnormal sleep EEG → CSWS — Landau-Kleffner variant
Treatment / prognosis
- Ethosuximide first-line, best attention outcome (CAE trial) → Childhood absence epilepsy
- Often no AED needed; if treated, LEV / OXC / VPA monotherapy; AVOID polytherapy → SeLECTS / BECTS
- Lifelong epilepsy with high relapse; AVOID lamotrigine; VPA ± LEV / clonazepam → Jeavons syndrome
- AVOID CBZ / OXC / PHT / GBP / PGB / TGB / VGB — worsen seizures, may trigger absence status → Absence & myoclonic epilepsies
- High-dose benzodiazepine pulse → corticosteroids / IVIG, clobazam; treat the EEG, not just seizures → CSWS / ESES
- Benign, self-limited, remits by adolescence even without therapy → SeLECTS & Panayiotopoulos
Febrile Seizures
Simple vs Complex Febrile Seizures
| Feature | Simple FS | Complex FS |
|---|---|---|
| Duration | <15 minutes | ≥15 minutes (febrile SE if ≥30 min) |
| Focal features | No — generalized (GTC) | Yes — clonic activity lateralized, eye deviation |
| Recurrence within 24 h | Single episode only | >1 seizure in the same febrile illness |
| Frequency | ~70–75% of all FS | ~25–30% of all FS |
| Risk of epilepsy | 1–2% (same as general population) | 4–6% (up to 10% with multiple complex features) |
| Todd paralysis | No | May occur after prolonged focal seizures |
Recurrence Risk Factors
- Age <18 months at first febrile seizure (strongest predictor)
- Lower temperature at the time of seizure
- Shorter duration of fever before seizure onset
- Family history of febrile seizures (first-degree relative)
- Complex features on the initial seizure
- Overall recurrence rate: ~1/3 of children with a first FS
Investigation — AAP Guidelines
- Simple FS: No routine EEG, no neuroimaging, no labs
- LP: Consider if age 6–12 months with incomplete immunization or if meningeal signs present
- Complex FS: Consider EEG if focal/prolonged/recurrent; MRI if abnormal neuro exam or developmental delay
- Antipyretics do NOT prevent FS recurrence; continuous daily ASM prophylaxis NOT recommended
FEBSTAT Study
- Prolonged febrile seizures (≥30 min) → acute hippocampal injury (T2 signal on MRI)
- Subset develops mesial temporal sclerosis (MTS) → temporal lobe epilepsy (TLE)
- Supports the “two-hit” hypothesis: prolonged febrile SE + predisposed brain → MTS → drug-resistant TLE
SeLECTS (Self-Limited Epilepsy with Centrotemporal Spikes)
Key Features
- Formerly: BECTS / benign rolandic epilepsy
- Most common childhood focal epilepsy — 15–25% of all childhood epilepsies
- Onset: 4–10 years (peak 7–10); slight male predominance
- Remission in virtually all by age 16; EEG typically normalizes by mid-to-late adolescence, often after clinical remission
Seizure Semiology
- Hemifacial sensorimotor seizures: unilateral clonic jerking of face/mouth, tingling of tongue/lips/cheek
- Drooling (sialorrhea) and speech arrest (oropharyngolaryngeal involvement) with preserved consciousness
- Often from drowsiness, sleep onset, or just before awakening (sleep-wake transitions); ~75% are exclusively nocturnal; may secondarily generalize during sleep
- Brief: 30 sec to 2 min; infrequent (most have <10 lifetime seizures)
EEG
- Centrotemporal spikes: high-amplitude, biphasic/triphasic sharp waves at C3/C4 or C5/C6
- Horizontal dipole: negative over temporal, positive over frontal (board favorite)
- Sleep-activated: spike frequency markedly increases in NREM sleep
- Bilateral independent in ~30%; normal background (essential to distinguish from encephalopathies)
Treatment
- Many children require no treatment (infrequent, nocturnal, self-limited)
- If treatment needed: LEV, CBZ, OXC (sulthiame in Europe)
- Discontinue after 1–2 years seizure-free or by age 14–16
- Avoid overtreatment — overtreatment carries more risk than the epilepsy itself
Atypical Evolution of SeLECTS
- A small subset may develop more frequent seizures, cognitive decline, and EEG features of CSWS/ESES
- Red flags: language regression, behavioral deterioration, declining school performance
- If suspected → obtain overnight EEG to assess for spike-wave activation in sleep
- Presence of GRIN2A variants associated with higher risk of atypical evolution
Continue reading — sign in
The full note has more clinical pearls, tables, and board-focused tips. Free account, no fee.